Jumnongprakho P, Govitrapong P, Tocharus C, Tocharus J
This article keeps the evidence separated by weight and situation
Welcome to the PlexusDx Education Hub, where we unpack GLP-1 therapies, weight-management protocols, and the genetic factors sitting underneath every metabolic decision
Eligibility for Eden's Weight Loss Guarantee Program is subject to strict published requirements and does not represent a guarantee of treatment outcomes
Labeling across this class advises against concomitant use with other GLP-1 receptor agonists, and stacking a residual supply of one medication onto a newly started one is the most predictable way to turn a routine transition into a serious adverse event
Many may need to continue taking GLP-1 medications in order to maintain their weight loss and health goals The doses of medication may stay the same or may be reduced to find the lowest effective dose that maintains weight and health Lifestyle and behavioural changes in the maintenance phase are crucial Any reduction or stopping of GLP-1 medication should be done under medical supervision, gradually Monitor weight and appetite vigilantly Many people will find that they can use a reduced dose of GLP-1 medication once they have achieved their target BMI